Paul Di Cesare,MD
Quick facts
Marketed products
- Fondaparinux Sodium (Arixtra) · Cardiovascular
Fondaparinux selectively inhibits Factor Xa, a key enzyme in the coagulation cascade, preventing thrombin generation and blood clot formation.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: